Literature DB >> 10620065

Coordinated expression of noggin and bone morphogenetic proteins (BMPs) during early skeletogenesis and induction of noggin expression by BMP-7.

A Nifuji1, M Noda.   

Abstract

Coordinated regulation of the activities of bone morphogenetic protein (BMP) and its inhibitors is essential for skeletal development since loss-of-function experiments show that both BMPs and BMP inhibitory signals, such as noggin, are required to establish proper formation of skeletal tissues. In this paper, we asked how and when noggin would be functional to interact with BMPs during skeletogenesis in mammals. For this purpose, we first analyzed the spatial and temporal patterns of noggin, BMP-2, BMP-4, and BMP-7 expression during early skeletogenesis in mouse embryos. In situ hybridization study revealed that noggin expression was detected at a low level in limb mesenchyme, whereas BMP-7 was expressed at a high level throughout limb mesenchyme 10.5 days postcoitum (dpc) in mouse embryos. One day later, noggin mRNA was expressed at a high level in the prechondrogenic condensations in appendicular and axial skeletal primordia, where sox9 transcripts were also expressed. At this stage, noggin-expressing cells were surrounded by those expressing BMP-7. The chondrogenic cell condensation continued to express noggin transcripts in 12.5 dpc and 13.5 dpc embryos, and again the noggin-expressing cells within the cartilaginous tissue were surrounded by those expressing BMP-7. We further examined interaction of noggin and BMPs by using organ cultures of 11.5 dpc mouse forelimbs and found that implantation of carriers containing BMP-7 protein into the forelimb explants induced noggin expression in the limb mesenchyme. BMP-7 also induced type II collagen and sox9 mRNAs in the same cell population, indicating that noggin induction occurred in the chondrogenic precursor cells. BMP-7 effects on noggin expression were observed in a dose-dependent manner within a dose range of 10-100 ng/microliter. These results suggest that BMP-7 induced expression of noggin transcripts within skeletal cell condensation and that this noggin expression in turn could act antagonistically to attenuate BMP action in the early skeletogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10620065     DOI: 10.1359/jbmr.1999.14.12.2057

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  16 in total

1.  Noggin is required for early development of murine upper incisors.

Authors:  X Hu; Y Wang; F He; L Li; Y Zheng; Y Zhang; Y P Chen
Journal:  J Dent Res       Date:  2012-02-02       Impact factor: 6.116

2.  A Balance between Secreted Inhibitors and Edge Sensing Controls Gastruloid Self-Organization.

Authors:  Fred Etoc; Jakob Metzger; Albert Ruzo; Christoph Kirst; Anna Yoney; M Zeeshan Ozair; Ali H Brivanlou; Eric D Siggia
Journal:  Dev Cell       Date:  2016-10-13       Impact factor: 12.270

3.  H3K9MTase G9a is essential for the differentiation and growth of tenocytes in vitro.

Authors:  Satoshi Wada; Hisashi Ideno; Akemi Shimada; Taichi Kamiunten; Yoshiki Nakamura; Kazuhisa Nakashima; Hiroshi Kimura; Yoichi Shinkai; Makoto Tachibana; Akira Nifuji
Journal:  Histochem Cell Biol       Date:  2015-03-27       Impact factor: 4.304

4.  Coordinated expression of H3K9 histone methyltransferases during tooth development in mice.

Authors:  Taichi Kamiunten; Hisashi Ideno; Akemi Shimada; Yoshiki Nakamura; Hiroshi Kimura; Kazuhisa Nakashima; Akira Nifuji
Journal:  Histochem Cell Biol       Date:  2014-10-08       Impact factor: 4.304

5.  Gene therapy of bone morphogenetic protein for periodontal tissue engineering.

Authors:  Q M Jin; O Anusaksathien; S A Webb; R B Rutherford; W V Giannobile
Journal:  J Periodontol       Date:  2003-02       Impact factor: 6.993

6.  Noggin gene delivery inhibits cementoblast-induced mineralization.

Authors:  Q-M Jin; M Zhao; A N Economides; M J Somerman; W V Giannobile
Journal:  Connect Tissue Res       Date:  2004       Impact factor: 3.417

7.  A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN.

Authors:  K Lehmann; P Seemann; F Silan; T O Goecke; S Irgang; K W Kjaer; S Kjaergaard; M J Mahoney; S Morlot; C Reissner; B Kerr; A O M Wilkie; S Mundlos
Journal:  Am J Hum Genet       Date:  2007-06-08       Impact factor: 11.025

8.  Altered BMP-Smad4 signaling causes complete cleft palate by disturbing osteogenesis in palatal mesenchyme.

Authors:  Nan Li; Jing Liu; Han Liu; Shangqi Wang; Ping Hu; Hailing Zhou; Jing Xiao; Chao Liu
Journal:  J Mol Histol       Date:  2020-11-07       Impact factor: 2.611

9.  Multiple tissue-specific requirements for the BMP antagonist Noggin in development of the mammalian craniofacial skeleton.

Authors:  Maiko Matsui; John Klingensmith
Journal:  Dev Biol       Date:  2014-06-17       Impact factor: 3.582

10.  Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.

Authors:  Petra Seemann; Anja Brehm; Jana König; Carsten Reissner; Sigmar Stricker; Pia Kuss; Julia Haupt; Stephanie Renninger; Joachim Nickel; Walter Sebald; Jay C Groppe; Frank Plöger; Jens Pohl; Mareen Schmidt-von Kegler; Maria Walther; Ingmar Gassner; Cristina Rusu; Andreas R Janecke; Katarina Dathe; Stefan Mundlos
Journal:  PLoS Genet       Date:  2009-11-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.